New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For GSK;AAPL;BEN;GE;AZN;DELL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | all recent news | >>
October 7, 2014
09:36 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:46 EDTAAPLFireEye announces targeted attack protection for Apple platform
Subscribe for More Information
08:15 EDTAAPLApple leaks point to iPad Air 2 with Touch ID, gold color, Michael Report says
Subscribe for More Information
07:48 EDTAZNSalix reinstated with a Buy at Jefferies
Subscribe for More Information
06:14 EDTAAPLSamsung may find difficulty competing with TSMC for Apple chips, DigiTimes says
Subscribe for More Information
06:11 EDTAAPLApple adjusts supply ratio for iPhone 6 and iPhone 6 Plus, DigiTimes reports
Subscribe for More Information
06:09 EDTAAPLApple 12-inch tablet may integrate both Mac OS and iOS, DigiTimes reports
Subscribe for More Information
06:06 EDTAAPLApple reinstated with a Buy at BofA/Merrill
Subscribe for More Information
October 6, 2014
16:20 EDTAAPLOn The Fly: Closing Wrap
Stocks on Wall Street opened in positive territory and appeared ready to ride the wave of optimism from Friday’s jobs report into the new week. However, with little on the economic calendar to sustain the momentum, each of the major equity indexes had given up their gains by noon. The Dow and S&P 500 made it back to flat late in the session, but weakened into the close to end the day slightly lower. The tech-heavy Nasdaq was the laggard throughout and ended the day with the most significant decline. ECONOMIC EVENTS: In the U.S., no major economic data was reported. COMPANY NEWS: Hewlett-Packard (HPQ) climbed $1.67, or 4.74%, to $36.87 after it confirmed plans to split itself into two publicly traded companies by the end of its fiscal 2015. One company will include HP's technology infrastructure, software and services businesses, to be known as "Hewlett-Packard Enterprise," while the other will include the company's PC and printing businesses and be called "HP Inc." After the announcement, HP shares were upgraded to Outperform from Neutral at Credit Suisse, while analysts at Cantor called the split "a bold and smart move" that will give HP the financial flexibility needed to sell off one or both of the PC and printing businesses if an attractive offer emerges for either or both. MAJOR MOVERS: Among the notable gainers was Durata Therapeutics (DRTX), which surged $10.36, or 74.64%, to $24.24 after the company agreed to be acquired by larger drugmaker Actavis (ACT) for $23.00 per share in cash, or approximately $675M, and contingent value rights for additional cash payments of up to $5.00 per share if certain regulatory or commercial milestones related to Durata's lead product are achieved. Also higher was CareFusion (CFN), which jumped $10.58, or 22.92%, to $56.75 after agreeing to be acquired by Becton Dickinson (BDX) for $49 in cash and 0.0777 of a share of BD for each share of CareFusion, or about $12.2B. Becton Dickinson rose $9.14, or 7.89%, to $124.98 after its deal, while Actavis slipped $2.12, or 0.86%, to $243.95, after its own, much smaller purchase. GT Advanced Technologies (GTAT) plunged $10.22, or 92.46%, to 83c after the company announced that it and some of its units had commenced voluntary cases under chapter 11 of the bankruptcy code, which Raymond James believes implies a "fundamental, severe breakdown" of the company's relationship with Apple (AAPL). Also lower were shares of Sunesis (SNSS), which dropped $5.18, or 78.01%, to $1.46 and was downgraded at RBC Capital and Wells Fargo after a trial of a combination therapy for patients with first relapsed or refractory acute myeloid leukemia did not meet its primary endpoint. INDEXES: The Dow slid 17.78, or 0.1%, to 16,991.91, the Nasdaq fell 20.82, or 0.47%, to 4,454.80, and the S&P 500 slipped 3.08, or 0.16%, to 1,964.82.
16:00 EDTAAPLOptions Update; October 6, 2014
iPath S&P 500 VIX Short-Term Futures up 46c to 30.08. Option volume leaders: AAPL TSLA TWTR AMZN FB NFLX HPQ C RSH CLF PBR according to Track Data.
14:01 EDTAAPLGT Advanced bankruptcy implies breakdown with Apple, says Raymond James
Subscribe for More Information
11:41 EDTAAPLSolar companies sink after GT Advanced declares bankruptcy
Subscribe for More Information
10:38 EDTAAPLApple's iPhone 6, 6 Plus to launch in India on October 17, Times of India says
Apple's iPhone 6 and iPhone 6 Plus will be available in India beginning Friday, October 17 through authorized resellers, the Times of India reports. Pre-orders for the devices start on October 7. The 16GB version o the iPhone 6 will be available at Rs 53,500, the 64GB version is priced at Rs 62,500 and the 128GB version of the phone will sell for Rs 71,500; the 16GB version of the iPhone 6 Plus will be available for Rs 62,500, while the 64GB version will cost Rs 71,500 and the 128GB version will sell for Rs 80,500. Reference Link
10:19 EDTGEGeneral Electric names John Flannery as GE Healthcare president and CEO
GE Chairman and CEO Jeff Immelt announced the appointment of John Flannery as president and CEO of GE Healthcare succeeding John Dineen, who is leaving GE. The appointment is effective immediately. Flannery most recently was SVP of business development for GE.
09:37 EDTAAPLActive equity options trading on open
Subscribe for More Information
07:42 EDTAAPLSkyworks well positioned to benefit from iPhone upgrade cycle, says Canaccord
Subscribe for More Information
07:34 EDTAAPLApple updates software to protect against iWorm bug, MacRumors reports
Subscribe for More Information
07:32 EDTAZNAstraZeneca confirms AHA, ACC updated guideline
AstraZeneca confirmed that the American Heart Association and American College of Cardiology have updated the guideline for the management of patients with non–ST-elevation acute coronary syndromes. The guideline supports differentiation among currently available P2Y12 inhibitors, including ticagrelor, clopidogrel, and prasugrel, for these patients. BRILINTA is now preferred over clopidogrel for the management of NSTE-ACS patients who undergo an early invasive or ischemia-guided strategy or those who receive a coronary stent. This is the first time the AHA and ACC have recommended one P2Y12 over another in the treatment of acute coronary syndrome. The approved Prescribing Information for BRILINTA includes information about the approved uses for BRILINTA. BRILINTA has two Boxed WARNINGS, one for bleeding risk and the other for aspirin dose and reduced BRILINTA effectiveness. The Boxed WARNING on BLEEDING RISK states, like other antiplatelet agents, BRILINTA can cause significant, sometimes fatal, bleeding.
07:16 EDTAAPLiOS 8 adoption appear slower than its predecessors, 9to5Mac reports
Subscribe for More Information
06:25 EDTAAPLiPhone 6 chip orders to remain high in 1Q15, DigiTimes reports
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use